Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to ...

The following is a summary of “Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid ...

used in combination with ThyGeNEXT ®, for the diagnosis of thyroid cancer utilizing a proprietary microRNA pairwise expression profiler along with algorithmic classification; and RespriDX ®, that ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

A large-scale study of low-risk thyroid cancer patients proved that the quality of life can be maintained with 'active ...

Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The immediate threat has passed, at least for now. But concern from individuals, businesses, nonprofits and local governments ...

Chicago Partners Investment Group LLC purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the ...

An Iranian knowledge-based company has managed to develop a new method for the synthesis of Technetium (99mTc) tilmanocept, a radiopharmaceutical diagnostic imaging agent used to determine lymph nodes ...